Receptor activator of nuclear factor kappa-B ligand (RANKL)/RANK signaling promotes cancer-related inflammation through M2 macrophages

Exp Dermatol. 2016 May;25(5):397-9. doi: 10.1111/exd.12949. Epub 2016 Feb 26.

Authors

Taku Fujimura¹, Yumi Kambayashi¹, Sadanori Furudate¹, Aya Kakizaki¹, Takanori Hidaka¹, Masayuki Asano¹, Setsuya Aiba¹

Affiliation

¹ Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

PMID: 27167703
DOI: 10.1111/exd.12949

No abstract available

Keywords: M2 macrophages; RANKL/RANK; extramammary Paget's disease; tolerance.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Macrophages / physiology*
Neoplasms / immunology*
RANK Ligand / metabolism*
Receptor Activator of Nuclear Factor-kappa B / metabolism*

Substances

RANK Ligand
Receptor Activator of Nuclear Factor-kappa B
TNFRSF11A protein, human
TNFSF11 protein, human